Ignite Creation Date:
2025-12-24 @ 1:56 PM
Ignite Modification Date:
2026-05-25 @ 5:24 AM
Study NCT ID:
NCT04043195
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-28
First Post:
2019-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
Sponsor:
Hatim Husain
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
181485
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None